KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Long-Term Investments (2016 - 2025)

Sarepta Therapeutics has reported Long-Term Investments over the past 13 years, most recently at $1.0 million for Q4 2025.

  • Quarterly results put Long-Term Investments at $1.0 million for Q4 2025, down 99.21% from a year ago — trailing twelve months through Dec 2025 was $1.0 million (down 99.21% YoY), and the annual figure for FY2025 was $1.0 million, down 99.21%.
  • Long-Term Investments for Q4 2025 was $1.0 million at Sarepta Therapeutics, down from $8.2 million in the prior quarter.
  • Over the last five years, Long-Term Investments for SRPT hit a ceiling of $391.0 million in Q1 2025 and a floor of $1.0 million in Q4 2025.
  • Median Long-Term Investments over the past 5 years was $18.5 million (2022), compared with a mean of $52.1 million.
  • Peak annual rise in Long-Term Investments hit 5143.4% in 2025, while the deepest fall reached 99.21% in 2025.
  • Sarepta Therapeutics' Long-Term Investments stood at $34.9 million in 2021, then fell by 10.23% to $31.3 million in 2022, then plummeted by 76.05% to $7.5 million in 2023, then soared by 1675.51% to $133.2 million in 2024, then tumbled by 99.21% to $1.0 million in 2025.
  • The last three reported values for Long-Term Investments were $1.0 million (Q4 2025), $8.2 million (Q3 2025), and $195.5 million (Q2 2025) per Business Quant data.